Submitted:
09 January 2024
Posted:
09 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Etemad K, Mohseni P, Shojaei S, Mousavi SA, Taherkhani S, Atatalab FF, et al. Non-Pharmacologic Interventions in COVID-19 Pandemic Management; a Systematic Review. Arch Acad Emerg Med 2023, 11, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Andrejko KL, Pry JM, Myers JF, Fukui N, DeGuzman JL, Openshaw J, et al. Effectiveness of Face Mask or Respirator Use in Indoor Public Settings for Prevention of SARS-CoV-2 Infection — California, February–December 2021. MMWR Recomm Reports 2022, 71, 212–216. [Google Scholar] [CrossRef]
- Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: Systematic review and meta-analysis. BMJ 2021, 375, 1–15. [Google Scholar] [CrossRef]
- Cui Q, Hu Z, Li Y, Han J, Teng Z, Qian J. Dynamic variations of the COVID-19 disease at different quarantine strategies in Wuhan and mainland China. J Infect Public Health 2020, 13, 849–855. [Google Scholar] [CrossRef] [PubMed]
- Gettings J, Czarnik M, Morris E, Haller E, Thompson-Paul AM, Rasberry C, et al. Mask Use and Ventilation Improvements to Reduce COVID-19 Incidence in Elementary Schools — Georgia, November 16–December 11, 2020. MMWR Morb Mortal Wkly Rep 2021, 70, 779–784. [Google Scholar] [CrossRef] [PubMed]
- 6. Madhusudanan A, Iddon C, Cevik M, Naismith JH, Fitzgerald S. Non-pharmaceutical interventions for COVID-19: A systematic review on environmental control measures. Philos Trans R Soc A Math Phys Eng Sci, 2023; 381. [CrossRef]
- Silubonde-Moyana TM, Draper CE, Norris SA. Effectiveness of behavioural interventions to influence COVID-19 outcomes: A scoping review. Prev Med (Baltim) 2023, 172, 107499. [Google Scholar] [CrossRef] [PubMed]
- Tong KK, Chen JH, Yu EW yat, Wu AMS. Adherence to COVID-19 Precautionary Measures: Applying the Health Belief Model and Generalised Social Beliefs to a Probability Community Sample. Appl Psychol Heal Well-Being 2020, 12, 1205–1223. [Google Scholar] [CrossRef] [PubMed]
- Beca-Martínez MT, Romay-Barja M, Falcón-Romero M, Rodríguez-Blázquez C, Benito-Llanes A, Forjaz MJ. Compliance with the main preventive measures of COVID-19 in Spain: The role of knowledge, attitudes, practices, and risk perception. Transbound Emerg Dis 2022, 69, e871–82. [Google Scholar] [CrossRef] [PubMed]
- Wise T, Zbozinek TD, Michelini G, Hagan CC, Mobbs D. Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States: COVID-19 risk perception and behavior. R Soc Open Sci 2020, 7. [Google Scholar] [CrossRef]
- Islam JY, Vidot DC, Camacho-Rivera M. Determinants of COVID-19 preventive behaviours among adults with chronic diseases in the USA: An analysis of the nationally representative COVID-19 impact survey. BMJ Open 2021, 11, 1–9. [Google Scholar] [CrossRef]
- World Health Organization. Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline. 2023, 78.
- Aho Glele LS, de Rougemont A. Non-Pharmacological Strategies and Interventions for Effective COVID-19 Control: A Narrative Review. J Clin Med 2023, 12. [Google Scholar] [CrossRef]
- Wu N, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med 2023, 11, 439–452. [Google Scholar] [CrossRef]
- Si R, Yao Y, Zhang X, Lu Q, Aziz N. Investigating the Links Between Vaccination Against COVID-19 and Public Attitudes Toward Protective Countermeasures: Implications for Public Health. Front Public Heal 2021, 9, 1–11. [Google Scholar] [CrossRef]
- Agurto-Ramírez A, Pino-Rosón C, Ayala A, Falcón M, Rodríguez-Blázquez C, Forjaz MJ, et al. Association Between Pandemic Fatigue and Disease Knowledge, Attitudes, Concerns, and Vaccination Intention at Two Key Moments of the COVID-19 Pandemic. Int J Public Health 2023, 68, 1–10. [Google Scholar] [CrossRef]
- Petherick A, Goldszmidt R, Andrade EB, Furst R, Hale T, Pott A, et al. A worldwide assessment of changes in adherence to COVID-19 protective behaviours and hypothesized pandemic fatigue. Nat Hum Behav 2021, 5, 1145–1160. [Google Scholar] [CrossRef]
- 18. Gassen J, Nowak TJ, Henderson AD, Weaver SP, Baker EJ, Muehlenbein MP. Longitudinal changes in COVID-19 concern and stress: Pandemic fatigue overrides individual differences in caution. J Public Health Res. [CrossRef]
- Ministerio de Salud de Chile. Reporte diario 30 de noviembre de 2021. Santiago: 2021.
- Ngamchaliew P, Kaewkuea N, Nonthasorn N, Vonnasrichan T, Rongsawat N, Rattanachai L, et al. Changes in preventive behaviour after COVID-19 vaccination in Thailand: a cross-sectional study. BMC Public Health 2022, 22, 1–12. [Google Scholar] [CrossRef]
- 21. Rahamim-Cohen, D; Gazit, S; Perez, G; Nada, B; Moshe, SB; Mizrahi-Reuvenil ,M; Azuri, J; Patalon T. Survey of Behaviour Attitudes Towards Preventive Measures Following COVID-19 Vaccination. MedRxiv. [CrossRef]
- Wright L, Steptoe A, Mak HW, Fancourt D. Do people reduce compliance with COVID-19 guidelines following vaccination? A longitudinal analysis of matched UK adults. J Epidemiol Community Health 2022, 76, 109–115. [Google Scholar] [CrossRef]
- Horga NG, Cirnatu D, Kundnani NR, Ciurariu E, Parvu S, Ignea AL, et al. Evaluation of Non-Pharmacological Measures Implemented in the Management of the COVID-19 Pandemic in Romania. Healthc 2022, 10, 1–13. [Google Scholar] [CrossRef]
- Abbas Alshami; Steven Douedi; Daniel Shenouda; Ali Nadhim; Joseph Varon; , Patel Swapnil. Incidence of Influenza Virus Pneumonia During the Time of Coronovirus-2019 Pandemic. Chest 2021, 4, A589. [Google Scholar] [CrossRef]
- Ministerio de Salud de Chile. Reporte Diario. 15 De Noviembre De 2021. Santiago: 2021.
- MInisterio de Salud de Chile. Reporte Diario. 15 de abril de 2022. 2022. [Google Scholar]
- Ministerio de salud de Chile. Reporte Diario. 15 de mayo de 2022. 2022. [Google Scholar]
- Hormazábal J, Nuñez-Franz L, Rubilar P, Apablaza M, Vial C, Cortés LJ, et al. Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study. Vaccine X 2023, 15, 1–7. [Google Scholar] [CrossRef]
- Vitiello, Antonio; Ferrara, Francesco; Auti, Amogh M; Marina, Di Domenico, Marina; Boccellino M. Advances in the Omicron variant development. J Intern Med 2022, 1, 81–90. [Google Scholar] [CrossRef]
- Binka M, Adu PA, Jeong D, Vadlamudi NK, García HAV, Mahmood B, et al. The Impact of Mask Mandates on Face Mask Use During the COVID-19 Pandemic: Longitudinal Survey Study. JMIR Public Heal Surveill 2023, 9, 1–14. [Google Scholar] [CrossRef]
- Fadaei, A. Importance of ventilation to prevent spread of covid 19. Eur J Sustain Dev Res 2021, 5, em0157. [Google Scholar] [CrossRef]
- Kebede Y, Yitayih Y, Birhanu Z, Mekonen S, Ambelu A. Knowledge, perceptions and preventive practices towards COVID-19 early in the outbreak among Jimma university medical center visitors, Southwest Ethiopia. PLoS One 2020, 15, 1–15. [Google Scholar] [CrossRef]
- Looi, KH. Explicating gender disparity in wearing face masks during the COVID-19 pandemic. BMC Public Health 2022, 22, 1–9. [Google Scholar] [CrossRef]
- Urbán R, Király O, Demetrovics Z. Who complies with coronavirus disease 2019 precautions and who does not? Curr Opin Psychiatry 2021, 34, 363–368. [Google Scholar] [CrossRef]
- Biblioteca del Congreso Nacional. Reportes Comunales. Indicadores demográficos 2023. https://www.bcn.cl/siit/reportescomunales/comunal.html?unidad=Comunales&anno=2023.
- Chong YY, Chien WT, Cheng HY, Chow KM, Kassianos AP, Karekla M, et al. The role of illness perceptions, coping, and self-efficacy on adherence to precautionary measures for COVID-19. Int J Environ Res Public Health 2020, 17, 1–11. [Google Scholar] [CrossRef]
- Corea F, Folcarelli L, Napoli A, del Giudice GM, Angelillo IF. The Impact of COVID-19 Vaccination in Changing the Adherence to Preventive Measures: Evidence from Italy. Vaccines 2022, 10, 1–11. [Google Scholar] [CrossRef]
- Nikoloski Z, Bain R, Elzalabany MK, Hanna P, Aynsley TR, Samhouri D, et al. Modelling COVID-19 vaccination status and adherence to public health and social measures, Eastern Mediterranean Region and Algeria. Bull World Health Organ 2023, 101, 111–120. [Google Scholar] [CrossRef]
- Organización Mundial de la Salud. Vigilancia de salud pública en relación con la COVID-19. Vigil Salud Pública En Relac Con La COVID-19 Orientaciones Provicionales. 2020, 1, 1–12.
- Subsecretaría de Salud Pública. Actualización de la definición de caso sospechoso, confirmado, probable, personas en alerta COVID-19 y contacto estrecho de brotes confirmados y priorizados; periodos de aislamiento; para vigilancia epidemiológica ante pandemia de COVID-19 en Chile. 2021, 2021, 15.


| Preventive measures | Year 2021 | Year 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 positive | COVID-19 positive | ||||||||||
| n | % | n | % | p-value | n | % | n | % | p-value | ||
| Frequency of handwashing | Always | 274 | 71 | 25 | 9.1 | 1 | 392 | 75.7 | 68 | 23.3 | 0.883 |
| Often | 101 | 26.2 | 9 | 8.9 | 81 | 21 | 18 | 22.2 | |||
| Rarely | 11 | 2.9 | 1 | 9.1 | 13 | 3.4 | 2 | 15.4 | |||
| Never | 0 | ||||||||||
| Frequency of avoiding handshakes, kisses, or hugs | Always | 234 | 61.4 | 18 | 7.7 | 0,33 | 227 | 59 | 51 | 22.5 | 0.805 |
| Often | 99 | 26 | 9 | 9.1 | 90 | 23,4 | 21 | 23.3 | |||
| Rarely | 37 | 9.7 | 6 | 16.2 | 44 | 11,4 | 12 | 27.3 | |||
| Never | 11 | 2.89 | 1 | 9.1 | 24 | 6,2 | 4 | 16.7 | |||
| Frequency of ventilating | Always | 324 | 84.2 | 31 | 9.6 | 0.096 | 339 | 87,8 | 69 | 20.4 | 0.006 |
| Often | 45 | 11.7 | 2 | 4.4 | 37 | 9,6 | 14 | 37.8 | |||
| Rarely | 15 | 3.9 | 1 | 6.7 | 9 | 2,3 | 5 | 55.6 | |||
| Never | 1 | 0.3 | 1 | 100 | 1 | 0,2 | 0 | 0 | |||
| Frequency of mask use in public places | Always | 370 | 95.9 | 32 | 8.7 | 0.092 | 346 | 89,9 | 78 | 22.5 | 0.935 |
| Often | 14 | 3.6 | 2 | 14.3 | 33 | 8,6 | 8 | 24.2 | |||
| Rarely | 2 | 0.5 | 1 | 50 | 6 | 1,6 | 1 | 16.7 | |||
| Never | 0 | 0 | 0 | 0 | |||||||
| Frequency of mask use with people outside of household members | Always | 213 | 55.3 | 15 | 7 | 0.39 | 349 | 90,7 | 77 | 22.1 | 0.627 |
| Often | 90 | 23.4 | 11 | 12.2 | 29 | 7,5 | 8 | 27.6 | |||
| Rarely | 56 | 14.6 | 6 | 10.7 | 7 | 1,8 | 2 | 28.6 | |||
| Never | 26 | 6.8 | 3 | 11.5 | |||||||
| Compliance with curfew | Always | 365 | 94.6 | 33 | 9 | 0.681 | |||||
| Often | 14 | 3.6 | 2 | 14.3 | |||||||
| Rarely | 5 | 1.3 | |||||||||
| Never | 2 | 0.5 | |||||||||
| Compliance with mobility restrictions | Always | 367 | 95.1 | 32 | 8.7 | 0.059 | |||||
| Often | 13 | 3.4 | 1 | 7.7 | |||||||
| Rarely | 3 | 0.8 | 0 | 0 | |||||||
| Never | 3 | 0.8 | 2 | 66.7 | |||||||
| Physical distancing of at least 1 meter | Always | 287 | 74.6 | 62 | 21.6 | 0.648 | |||||
| Often | 74 | 19.2 | 21 | 28.4 | |||||||
| Rarely | 17 | 4.4 | 4 | 23.5 | |||||||
| Never | 7 | 1,8 | 1 | 14.3 | |||||||
| Year 2021 | Year 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | n | Median | RIC | P-value | n | Median | RIC | P-value | |
| City | Coquimbo | 184 | 18 | 17-19 | 0.0012 | 184 | 19 | 18-20 | 0.5432 |
| Talca | 202 | 19 | 17-20 | 202 | 19 | 18-20 | |||
| Gender | Male | 126 | 18 | 17-19 | 0.0268 | 126 | 19 | 17-20 | 0.0507 |
| Female | 260 | 19 | 17-20 | 260 | 19 | 18-20 | |||
| Health Insurance | Public Insurance | 313 | 18 | 17-20 | 0.569 | 313 | 19 | 18-20 | 0.178 |
| Private Insurance | 52 | 18 | 17-19.5 | 52 | 20 | 18-20 | |||
| Age | 7-19 | 42 | 17 | 16-19 | 0.0001 | 42 | 18 | 16-19 | 0.0001 |
| 20-29 | 41 | 17 | 16-18 | 41 | 18 | 17-20 | |||
| 30-49 | 111 | 19 | 18-20 | 111 | 20 | 18-20 | |||
| 50-69 | 67 | 19 | 17-20 | 67 | 19 | 18-20 | |||
| 70 and above | 125 | 19 | 17-20 | 125 | 19 | 18-20 | |||
| Ethnicity | No | 360 | 19 | 17-20 | 0.103 | 360 | 19 | 18-20 | 0.5572 |
| Yes | 26 | 18 | 16-19 | 26 | 19 | 17-20 | |||
| Education at age 18 or older (n=351) | Elementary and lower | 52 | 19 | 18-20 | 0.5707 | 52 | 19 | 18-20 | 0.3823 |
| Secondary | 187 | 18 | 17-20 | 187 | 19 | 18-20 | |||
| Technical | 34 | 18,5 | 18-20 | 34 | 20 | 18-20 | |||
| Professional | 78 | 19 | 17-20 | 78 | 19 | 18-20 | |||
| In-person work (n=386) | No | 99 | 19 | 17-20 | 0.3041 | 195 | 19 | 18-20 | 0.0282 |
| Yes | 287 | 18 | 17-20 | 191 | 19 | 17-20 | |||
| Healthcare worker (n=191) | No | 179 | 18 | 17-20 | 0.4087 | 179 | 19 | 17-20 | 0.7504 |
| Yes | 12 | 19 | 18-20 | 12 | 19,5 | 18-20 | |||
| Episodes of illness (n=386) | No | 237 | 18 | 17-20 | 0.8021 | 209 | 19 | 18-20 | 0.086 |
| Yes | 149 | 18 | 17-19 | 177 | 19 | 18-20 | |||
| Number of episodes (n=177) | 1 | 98 | 18 | 17-20 | 0.4446 | 84 | 19 | 18-20 | 0.989 |
| 2 or more | 51 | 19 | 18-20 | 93 | 19 | 18-20 | |||
| COVID diagnosis (n=386) | No | 351 | 19 | 17-20 | 0.2769 | 298 | 19 | 18-20 | 0.6651 |
| Yes | 35 | 18 | 17-19 | 88 | 19 | 18-20 | |||
| Symptomatology (n=386) | No | 211 | 19 | 17-20 | 0.1778 | 19 | 18-20 | 0.1284 | |
| Yes | 175 | 18 | 17-19 | 19 | 18-20 | ||||
| Body mass index (n=359) | Malnourished | 18 | 19 | 17-20 | 0.2986 | 19 | 18-20 | 0.4567 | |
| Normal | 95 | 18 | 16-20 | 19 | 18-20 | ||||
| Overweight | 135 | 19 | 17-20 | 19 | 18-20 | ||||
| Obesity | 111 | 19 | 17-20 | 20 | 18-20 | ||||
| Comorbidity (n=386) | No | 153 | 18 | 17-19 | 0.0226 | 153 | 19 | 17-20 | 0.0403 |
| Yes | 233 | 19 | 17-20 | 233 | 20 | 18-20 | |||
| Tobacco (n=386) | No | 283 | 19 | 17-20 | 0.2362 | 283 | 19 | 18-20 | 0.4109 |
| Yes | 103 | 18 | 17-20 | 103 | 19 | 17-20 | |||
| Vaccine dosage (n=386) | No | 13 | 18 | 17-19 | 0.0001 | 6 | 20 | 20-20 | 0.0012 |
| Basal scheme (1 or 2 doses) | 191 | 18 | 17-19 | 28 | 18 | 17-19 | |||
| Basal scheme + 2 boosters | 182 | 19 | 18-20 | 213 | 19 | 18-20 | |||
| Basal scheme + 1 booster | 139 | 20 | 18-20 | ||||||
| Variables | 2021 | 2022 | |||||
|---|---|---|---|---|---|---|---|
| Coefficient | p-value | IC95% | Coefficient | p-value | IC95% | ||
| City | Coquimbo - La Serena | Ref. | Ref. | ||||
| Talca | 0.18 | 0.395 | -0.24- 0.62 | -0.002 | 0.986 | -0.33- 0.33 | |
| Gender | Male | Ref | Ref | ||||
| Female | 0.61 | 0.004 | 0.19 - 1.02 | 0.38 | 0.031 | -0.03 - 0.75 | |
| Age | 7-19 | ref | Ref | ||||
| 20-29 | -0.57 | 0.199 | -1.44 - 0.30 | -0.08 | 0.824 | -0.81- 0.65 | |
| 30-49 | 0.42 | 0.284 | -0.35- 1.18 | 0.86 | 0.009 | 0.22 - 1.51 | |
| 50-69 | 0.05 | 0.910 | -0.80 - 0.90 | 0.66 | 0.073 | -0.06 - 1.37 | |
| 70 and above | 0.28 | 0.535 | -0.60 - 1.16 | 0.67 | 0.075 | -0.06- 1.41 | |
| Body Mass Index | Malnourished | Ref | Ref | ||||
| Normal | -0.37 | 0.438 | -1.33-0.58 | 0.64 | 0.118 | -0.16-1.43 | |
| Overweight | 0.08 | 0.874 | -0.86-1.01 | 0.46 | 0.253 | -0.33-1.25 | |
| Obesity | 0.21 | 0.666 | -0.75- 1.18 | 0.68 | 0.093 | -0.11- 1.49 | |
| Comorbidity | No | Ref | |||||
| Yes | 0.11 | 0.621 | -0.34 - 0.58 | 0.14 | 0.445 | -0.24- 0.53 | |
| In-person work | No | Ref. | Ref | ||||
| Yes | -0.01 | 0.955 | -0.43 - 0.40 | -0.26 | 0.134 | -0.61- 0.08 | |
| COVID-19 | No | ref. | Ref | ||||
| Yes | -1.12 | 0.559 | -0.53- 0.29 | -0.18 | 0.273 | -0.53 - 0.15 | |
| Vaccine | No | Ref. | Ref. | ||||
| Basal scheme (1 or 2 doses) | -0.63 | 0.328 | -1.90-0.64 | -0.93 | 0.445 | -2.24- 0.53 | |
| Basal scheme + 2 boosters | 0.003 | 0.996 | -1.31 - 1.32 | -1.03 | 0.196 | -2.61 - 0.54 | |
| Basal scheme + 1 booster | -0.79 | 0.323 | -2.37 - 0.78 | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).